Precigen, Inc. has grown revenue −29% a year over three years and −21% a year over five. Revenue growth, 3-year annual rate: −29% (Biotechnology median +21%). Revenue growth, 5-year rate: −21%, growth has slowed since the five-year average. Years of annual history on file: 15, FY2011 to FY2025, as filed.

PGENPrecigen, Inc.

HealthcareUSD

$7.40

$1.7452 weeks$7.43

Is it growing?

Is PGEN growing?

Precigen, Inc. has grown revenue −29% a year over three years and −21% a year over five.

−29%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −21%
Revenue growth, 5-year rate · −29% over three · growth has slowed since the five-year average
Years of annual history on file: 15
Years of annual history on file · FY2011 to FY2025, as filed

Details›